Checking How to Better Diagnose and Treat Thyroid Nodules and Cancer
NCT00001160 · RecruitingThis study looks at patients who have thyroid nodules or thyroid cancer. The main goal is to learn more about how to diagnose and treat these conditions. Some tests will be routine medical care, while others will be for research. The study will also collect blood and tissue samples for further research and genetic studies.
Locations and contact
This trial is running at 1 location in the United States. It is currently recruiting.
United States1 location · 1 recruiting
- National Institutes of Health Clinical CenterBethesda, MarylandRecruiting
Who can join
This study is open to men and women of all ages, from 6 months to 98 years. It includes patients with thyroid nodules or thyroid cancer, as well as family members who may have a genetic risk for thyroid cancer. People with serious health issues that might affect their treatment cannot join. The trial team will confirm who is eligible.
What happens during the trial
Participants will be grouped based on whether they have thyroid cancer or thyroid nodules. Everyone will receive standard care, and some may also receive a special evaluation with a drug called 68-Gallium Dotatate. The study will monitor thyroid conditions as needed throughout the process.
The trial team
The trial is sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The principal investigator is Dr. Joanna Klubo-Gwiezdzinska from the same institute.
Important dates
The trial started on June 1, 1977, and is currently enrolling new participants. It is expected to be updated last on June 18, 2026.
Additional information
The trial ID is NCT00001160. It is an observational study, which means it aims to learn more about thyroid conditions without testing a new treatment. About 2,500 participants are expected to take part, and it is not regulated by the FDA.
Other recruiting trials for the same condition, with the eligibility rules written in plain language.
Browse similar trials →Find a top oncologist who can tell you whether a trial is a sensible option for you.
Find a doctor →The cancer centers running studies like this one, and what each is known for.
Browse hospitals →